KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Raw Materials (2018 - 2025)

Globus Medical filings provide 8 years of Raw Materials readings, the most recent being $152.1 million for Q3 2025.

  • On a quarterly basis, Raw Materials rose 31.33% to $152.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $152.1 million, a 31.33% increase, with the full-year FY2024 number at $122.0 million, up 18.03% from a year prior.
  • Raw Materials hit $152.1 million in Q3 2025 for Globus Medical, down from $153.3 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $153.3 million in Q2 2025 to a low of $41.7 million in Q1 2021.
  • Median Raw Materials over the past 5 years was $75.0 million (2023), compared with a mean of $84.8 million.
  • Biggest five-year swings in Raw Materials: grew 5.48% in 2021 and later skyrocketed 71.32% in 2023.
  • Globus Medical's Raw Materials stood at $41.8 million in 2021, then skyrocketed by 44.25% to $60.3 million in 2022, then skyrocketed by 71.32% to $103.3 million in 2023, then grew by 18.03% to $122.0 million in 2024, then grew by 24.71% to $152.1 million in 2025.
  • The last three reported values for Raw Materials were $152.1 million (Q3 2025), $153.3 million (Q2 2025), and $118.6 million (Q1 2025) per Business Quant data.